We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INCPF market cap is 814.11M. The company's latest EPS is CNY -2.5278 and P/E is -1.29.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Revenue | 1.25M | 1.36M | 1.04B | 625.4M | 738.54M |
| Operating Income | -410.54M | -496.04M | -165.51M | -1.03B | -757.71M |
| Net Income | -2.14B | -391.4M | -64.55M | -886.59M | -631.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Assets | 2.62B | 4.54B | 7.4B | 10.32B | 9.92B |
| Total Liabilities | 5.56B | 1.38B | 1.74B | 2.68B | 2.74B |
| Total Equity | -2.95B | 3.16B | 5.66B | 7.64B | 7.18B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Operating | -79.75M | -172.52M | 167.06M | -565.55M | -671.34M |
| Investing | 47.47M | -1.11B | -1.73B | -1.73B | 666.91M |
| Financing | 362.94M | 2.24B | 2.54B | 3.09B | 1.31M |
| Market Cap | 814.11M |
| Price to Earnings Ratio | -1.29 |
| Price to Sales Ratio | 1.1 |
| Price to Cash Ratio | 0.1 |
| Price to Book Ratio | 0.11 |
| Dividend Yield | - |
| Shares Outstanding | 249.73M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 3.26 |
| 52 Week Low | 3.26 |
| Spread (Intraday) | 198.5k (100%) |
| Company Name | Innocare Pharma Ltd (PK) |
| Address |
the offices of ogier global (cayman) limited grand cayman 1-9009 |
| Website | https://www.innocarepharma.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
